TLIS

Talis Biomedical Corporation [TLIS] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

TLIS Stock Summary

Top 10 Correlated Stocks

TLIS

In the News

TLIS Financial details

Company Rating
-
Market Cap
15.46M
Income
-60.84M
Revenue
412K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
99
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
-1.14
Forward P/E
-
PEG
0.2
P/S
697.36
P/B
0.18
P/C
-
P/FCF
-4.58
Quick Ratio
10.41
Current Ratio
10.6
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-26.63
EPS next Y
-
EPS next Q
-
EPS this Y
-45.36%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
34.65%
Revenue last 5Y
-36.46%
Revenue Q/Q
98.68%
EPS Q/Q
-95.13%
-
-
-
-
SMA20
-0.62%
SMA50
1.27%
SMA100
-9.6%
Inst Own
-
Inst Trans
-
ROA
-12%
ROE
-12%
ROC
-0.81%
Gross Margin
-543%
Oper. Margin
-21867%
Profit Margin
-3501%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
4.35-9.32
52W High
-80.56%
52W Low
-56.25%
RSI
59.15
Rel Volume
0.06
Avg Volume
8.45K
Volume
500
Perf Week
0.57%
Perf Month
4.17%
Perf Quarter
-2.78%
Perf Half Y
1.74%
-
-
-
-
Beta
1.738
-
-
Volatility
0.08%, 0.08%
Prev Close
16.67%
Price
1.75
Change
16.67%

Something similar

Top by Market Cap
AMZN
M&M.NS
DHR-PB
1YD.DE
0YXG.L
Same Sector
CPHI
9987.T
CTSO
HALO
VTYX
Top Correlated Stocks
0HDY.L
POW.L
HFD.L
BNK.TO
FBP
Similar Market Cap
CYXO.ST
FIRMX
BRES.L
BEAB.BR
0HUZ.L

Company Profile

Healthcare Medical - Devices
  • Volume Average 8.45K
  • Market Capitalization 15.46M
  • Employee 99
  • CEO Mr. Robert Kelley MBA
  • Headquarters Menlo Park,CA,US
  • IPO Date 2021-02-12
  • Website https://talisbio.com

Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. In addition, it develops Talis One assay kit for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A, influenza B, and respiratory syncytial virus. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California.